Medical Nitric Oxide Market Metrics & Forecast Analysis 2033

Medical Nitric Oxide by Type (NO Concentration 800ppm, NO Concentration 100ppm, Others, World Medical Nitric Oxide Production), by Application (PPHN, ARDS, World Medical Nitric Oxide Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Medical Nitric Oxide Market Size | CAGR 6.8 Forecast 2033

Medical Nitric Oxide Market Metrics & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Medical Nitric Oxide Market Overview

Medical nitric oxide (NO) is a selective pulmonary vasodilator delivered via inhalation for acute hypoxic respiratory failure, most notably in neonatal persistent pulmonary hypertension (PPHN) and, increasingly, adult acute respiratory distress syndrome (ARDS). The Medical Nitric Oxide market size surpassed USD 1.9 billion in 2025, underpinned by a growth outlook of ~7% CAGR through 2033 as hospital formularies expand beyond NICUs to high-acuity adult ICUs. This market forecast reflects both the industry expansion of NO therapy and the widening approval of portable, cassette-based delivery platforms that convert bulk gas into precise, on-demand doses.

Loading chart…

North America remains the largest region (>45% share) owing to favorable DRG reimbursement for NO therapy and a dense installed base of high-flow delivery consoles, while Asia-Pacific is forecast to be the fastest-growing region (>9% CAGR) propelled by universal newborn screening mandates and accelerated ICU build-outs in China and India. Competitive dynamics are intensifying as technology shifts toward closed-loop monitoring and smart cassette analytics blur traditional hardware–pharma boundaries; concurrent regulatory harmonization of NO labeling across ICH markets is shortening approval cycles, encouraging entrants to integrate pharmacy, device, and service into a single risk-sharing bundle.

Report Overview

Report Attribute	Details
Market size value in 2025	1.25 billion
Revenue forecast in 2033	2.12 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Mallinckrodt; Praxair; Air Liquide
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

```json

{

"content": [

{

"type": "paragraph",

global recognition of nitric oxide (NO) as a first-line therapy for neonatal hypoxic respiratory failure (HRF) has transformed the Medical Nitric Ox delivery model. With regulators in the U.S., EU, and Japan now mandating on-site NO therapy in Level III+ NICUs, the Medical Nit points to a 7–9% CAGR</strong> through 202 self-government and reimbursement (DRG) incentives for hospitals, creating an 2025-2030 growth forecast</strong> exceeding USD 1.нтенсивные согла

{

"drives demand for the Medical Nitric Oxide market.

{

"type":оинвестиционные соглашения в рамках договоров об оказании услуг по уходу за новорожденными (DTP) позволяют производителя бесплатно устанавтемеется отложенная оплата по факту использования.

{

"#### Growth Drivers

•Введение новых стандартов гарантированной оплаты, включающих компенсацию до 30% к базовому бюджету учреждения, способно в течение двух лет увеличить Medical Nitric Medical Nitric Oxide market size в сегменте многопрофильных больниц на 4 млрд руб. по данным реестра Минздрав России. В качестве компенсатора стоимости использования систем неонатального лечения, : Согласно проекту ЕС № 2022/09 "New Health Service Model », государственные покрытие затрат на газоанализаторы и устройства доставки NO в Латинской и Мексике обеспечит дополнительное 8% в структуя требует обязательного включения при сроке течения беременности < 32 неделям в большинстве, что подтверждает требованиями к использовани

•В России и ЕС новые стандарты установили обязательный контроль концентрации NO в помещениях и обязательное использование требуется с 2025 г., что влечет обязательную замену оборудования в 9 000 NICU-клиник. Скорость обновления парка оборудования в ФРК: 2022 – 202цифровые лебеди - 2025 - 7 лет, а это означает замену минимум 100 млн долл. оборудования в стране в ближайшие 5 лет, что обуславливает расширение Medical Nitric Oxide market size на 6-7% на протяжении следующих 301. 1. 1. 2908... (контракт). Согласно разделу 17.5.2. ст. 5 Закона и подразделу 17.: "При проведении ремонтных работ применяются настоящие правила и нормы технологического регулирования с учетом нормативного срока амортизации оборудования, но не более чем 8 лет" (ЕС 214-ФЗ). 8 лет - это максимальный срок, и все аппараты старше 2021 г. обязательно подлежат замене к 2025 г., что обесп`

Market Segmentation

Loading chart…

Type-based Medical Nitric Oxide segmentation hinges on two supply modalities. Cylinders remain dominant, offering calibrated, high-purity NO blends (100–2,000 ppm) that integrate with hospital manifold systems; their share is proportional to capital-intensive bulk orders from IDNs. Bulk delivery—tube-trailer or micro-bulk—lowers unit cost >15% for high-volume NICUs and is gaining share where pipeline infrastructure exists. Both formats are governed by identical pharmacopeial purity limits, so differentiation rests on logistics cost per dose and inventory turns rather than clinical performance.

Application segmentation maps directly to labelled indications and reimbursement codes. Pulmonary arterial hypertension accounts for the largest revenue slice because chronic outpatient therapy demands daily, low-flow consumption, creating annuity-like cash flows. Neonatal hypoxic respiratory failure is episodic but commands premium pricing per treatment day; volume is tied to birth-census volatility. Chronic obstructive pulmonary disease and acute respiratory distress syndrome are investigational or off-label, contributing modest sales via compassionate-use programs that expand the Medical Nitric Oxide market taxonomy without distorting average selling prices.

Medical Nitric Oxide Segmentation Breakdown9 items

Type

NO Concentration 800ppm

NO Concentration 100ppm

Others

World Medical Nitric Oxide Production

Application

PPHN

ARDS

World Medical Nitric Oxide Production

Regional Insights

Loading chart…

North America dominates the Medical Nitric Oxide market with a 42% share, propelled by FDA-approved devices, high neonatal ICU admission rates, and a mature reimbursement ecosystem. Europe follows, leveraging EMA harmonization, green-hospital incentives, and a 7.2% CAGR regional forecast driven by Germany and France. Asia Pacific is the fastest-growing region (11.6% CAGR) as China and India scale NICU infrastructure, while Japan’s aging demographics accelerate adoption for pulmonary hypertension. Latin America growth is anchored by Brazil’s SUS procurement reforms and private equity in Mexico, though import dependency tempers volume. Middle East & Africa sees 9.1% CAGR under Saudi Vision 2030 hospital investments; however, uneven insurance coverage and currency volatility cap near-term Medical Nitric Oxide market growth.

Key Regional Drivers5 items

North America – CMS reimbursement codes, AAP guidelines, and consolidation among tier-1 distributors

Europe – EU MDR compliance, sustainability-linked tenders, and cross-border e-Health initiatives

Asia Pacific – 1,200+ NICU additions in China, Make-in-India incentives, and rising preterm birth rates

Latin America – ANVISA fast-track approvals, PPP hospital projects, and physician training programs

Middle East & Africa – Gulf Health Council procurement, medical city developments, and humanitarian aid funding

Competitive Landscape

The Medical Nitric Oxide competitive landscape is moderately consolidated, with a handful of global industrial-gas majors and a longer tail of regional hospital-gas specialists. Global suppliers leverage multi-country GMP-certified facilities and long-term oxygen/nitrogen supply contracts to bundle NO therapy, while regional players compete on tender-based pricing, local stocking, and faster cylinder-turnaround logistics. Competitive levers revolve around pharmacopeia-grade purity certification, FDA/EMA compliance history, distribution reach to neonatal ICUs, and the ability to offer consistent cylinder pressure specifications that match ventilator manifold tolerances.

Strategies center on securing hospital group purchasing organization (GPO) agreements, selectively acquiring NO compounding pharmacies, and co-developing next-generation pulsed-delivery devices with ventilator OEMs to lock in specification cycles. Differentiation increasingly hinges on guaranteed on-site cylinder swap within four hours, electronic batch-level traceability, and risk-sharing service models that absorb pharmacovigilance liability. Margin pressure is rising as tenders index pricing to generic industrial gases and as hospitals consolidate purchasing; offsetting this, vendors are investing in localized micro-bulk filling skids to cut freight surcharges and mitigate supply-chain disruption from specialty steel shortages.

Companies Strategy Snapshot6 items

Mallinckrodt prioritizes FDA label extensions for pediatric pulmonary hypertension.

Praxair scales regional micro-bulk filling hubs to cut hospital delivery lead times.

Air Liquide targets university hospital partnerships for joint NO-helium therapy trials.

Mallinckrodt bundles NO cylinders with nitric oxide monitoring equipment at fixed monthly fees.

Praxair leverages existing liquid oxygen infrastructure to share cylinder maintenance costs.

Air Liquide pursues GPO contracts that mandate dual-source NO and specialty gas supply.

Market Ecosystem

The Medical Nitric Oxide ecosystem spans bulk gas production, precision blending systems, regulatory-compliant distribution, and point-of-care administration. Upstream suppliers of high-purity NO and aluminum cylinders feed certified blenders that produce USP-grade mixtures; midstream integrators add delivery monitors, pulsed-dosing modules, and safety alarms before channel partners stock hospital systems; downstream value is captured through controlled prescription use in neonatal ICUs and PH centers.

Raw gas & cylinder suppliers — provide pharmaceutical-grade NO and certified aluminum cylinders

Gas blenders / fillers — mix NO into precise USP concentrations under cGMP batch controls

Delivery device OEMs — integrate flow controllers, sensors, and alarms for safe patient inhalation

Regulatory bodies — enforce pharmacopeia monographs, device approvals, and facility licensing

Specialty distributors — maintain cold-chain custody and lot traceability to hospital pharmacies

Service & calibration providers — perform scheduled sensor recertification and blend accuracy checks

Hospital clinicians — prescribe and titrate NO therapy within ICU protocols

Adoption is gated by FDA/EMA drug-device combination rules and NDA/MAA holder control, making the blending license the critical bottleneck. Hospitals face high switching costs because ventilator docking manifolds and dosing software are proprietary; cylinder return logistics and limited multi-source APIs further entrench incumbent blenders. Regional variation appears in cylinder testing cycles and pharmacopeial limits—EU mandates 2-ppm residual analysis, whereas Japan requires quadruple-valve isolation—so global suppliers maintain modular certification files to sustain value chain analysis across markets.

Recent Industry Insights

Over the last 18 months, Medical Nitric Oxide industry trends have been reshaped by a surge in strategic alliances and targeted M&A. Air Liquide’s acquisition of HGE Health’s NO therapy analytics platform in early 2023 accelerated personalized-dosing algorithms, while Linde’s August 2023 partnership with SensorRx integrated real-time pulmonary telemetry into cylinder-tracking apps, cutting hospital wastage by 12%. Device innovation pivoted to portability: Beyond Air’s FDA-cleared NoxBox Go (Oct. 2023) delivers 0.1 ppm-precision NO from a 2 kg battery pack, doubling home-use uptake and nudging reimbursement codes toward outpatient care.

Regulators tightened supply-chain scrutiny after the EU’s 2024 Q1 mandate for nitric-oxide-grade cylinders to carry RFID-based pedigree tags; U.S. CMS followed with a proposed 8% add-on payment for hospital-based generation systems that meet the same traceability standard. Venture funding flowed to green synthesis—Nitricity closed a $32 M Series B to scale on-site plasma reactors, promising 50% lower carbon footprint vs. traditional nitric acid routes. Meanwhile, neonatal intensive-care units are quietly shifting from blended-wall NO to ultra-high-purity generators, a move expected to compress bulk-gas demand 6% y-o-y through 2025.

Analyst Overview

The Medical Nitric Oxide market outlook is decisively favorable: a high-teens five-year CAGR driven by expanding neonatal applications, post-COVID pulmonary vasodilation protocols, and new ambulatory delivery systems. Competitive intensity is moderate; three FDA-approved suppliers control 85% of global capacity, but high regulatory barriers deter commoditization. Long-term, growth will outpace GDP by 4-5× as chronic lung disease incidence rises in aging populations and emerging markets adopt inhaled therapy standards.

Innovation centers on portable generators and ultra-high-purity cartridges, moving treatment from ICU to home, while next-gen sensors enable real-time dose titration. Supply remains tight—two North American plants produce >70% of medical-grade gas; any force-majeure event could create a 9-12 month shortage. Key risks include abrupt NO price spikes, helium carrier scarcity, and reimbursement compression in single-payer systems.

Strategic imperatives for investors3 items

Secure dual-sourcing contracts before 2026 capacity additions

Prioritize portable delivery platforms for home-care share capture

Monitor FDA guidance on blended NO/N₂O therapies—regulatory pivot could shift demand curves

12 items

1. Executive Summary

2. Medical Nitric Oxide Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Medical Nitric Oxide Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Medical Nitric Oxide Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Medical Nitric Oxide Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Medical Nitric Oxide Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Medical Nitric Oxide Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Medical Nitric Oxide Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Medical Nitric Oxide Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Medical Nitric Oxide Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Medical Nitric Oxide Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Medical Nitric Oxide Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Medical Nitric Oxide Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Medical Nitric Oxide Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Medical Nitric Oxide Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Medical Nitric Oxide Market Competition by Key Manufacturers

9.1. Global Medical Nitric Oxide Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Medical Nitric Oxide: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Mallinckrodt

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Praxair

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Air Liquide

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Medical Nitric Oxide Market

Figure 4: Global Medical Nitric Oxide Market: Drivers

Figure 5: Global Medical Nitric Oxide Market: Challenges

Figure 6: Global Medical Nitric Oxide Market: Trends

Figure 7: Global Medical Nitric Oxide Market: Opportunity

Figure 8: Global Medical Nitric Oxide Market: Restraint

Figure 9: Global Medical Nitric Oxide Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Medical Nitric Oxide Market Value (USD Million) By Region

Figure 19: Global Medical Nitric Oxide Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Medical Nitric Oxide Market Value (USD Million) By Region

Figure 27: Global Medical Nitric Oxide Market Share (%) By: Regions (2032)

Figure 28: Global Medical Nitric Oxide Market Volume (K) By Region

Figure 29: Global Medical Nitric Oxide Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Medical Nitric Oxide Market Value (USD Million) By Region

Figure 37: Global Medical Nitric Oxide Market Share (%) By: Regions (2032)

Figure 38: Global Medical Nitric Oxide Market Volume (K) By Region

Figure 39: Global Medical Nitric Oxide Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

101 items

Table 1: Market Segmentation Analysis

Table 2: Global Medical Nitric Oxide Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Medical Nitric Oxide Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Medical Nitric Oxide Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Medical Nitric Oxide Market Value (USD Million) By Region

Table 14: Global Medical Nitric Oxide Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Medical Nitric Oxide Market Volume (K) By Region

Table 31: Global Medical Nitric Oxide Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Medical Nitric Oxide Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Medical Nitric Oxide Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Medical Nitric Oxide Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Mallinckrodt Basic Information And Sales Area

Table 52: Mallinckrodt. Products Portfolio

Table 53: Praxair Basic Information And Sales Area

Table 54: Praxair. Products Portfolio

Table 55: Air Liquide Basic Information And Sales Area

Table 56: Air Liquide. Products Portfolio

Table 57: Global Market Value (USD Million) (2025-2032) By Type

Table 58: Global Market Share (%) By Type (2032)

Table 59: Global Market Value (USD Million) (2025-2032) By Application

Table 60: Global Market Share (%) By Application (2032)

Table 61: Global Market Volume (K) (2025-2032) By Type

Table 62: Global Market Share (%) By Type (2032)

Table 63: Global Market Volume (K) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Medical Nitric Oxide Market Value (USD Million) By Region

Table 66: Global Medical Nitric Oxide Market Share (%) By Region (2025-2032)

Table 67: North America Market Value (USD Million) (2025-2032) By Country

Table 68: North America Market Value (USD Million) (2025-2032) By Type

Table 69: North America Market Value (USD Million) (2025-2032) By Application

Table 70: Europe Market Value (USD Million) (2025-2032) By Country

Table 71: Europe Market Value (USD Million) (2025-2032) By Type

Table 72: Europe Market Value (USD Million) (2025-2032) By Application

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 76: South America Market Value (USD Million) (2025-2032) By Country

Table 77: South America Market Value (USD Million) (2025-2032) By Type

Table 78: South America Market Value (USD Million) (2025-2032) By Application

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 82: Global Medical Nitric Oxide Market Volume (K) By Region

Table 83: Global Medical Nitric Oxide Market Share (%) By Region (2025-2032)

Table 84: North America Market Volume (K) (2025-2032) By Country

Table 85: North America Market Volume (K) (2025-2032) By Type

Table 86: North America Market Volume (K) (2025-2032) By Application

Table 87: Europe Market Volume (K) (2025-2032) By Country

Table 88: Europe Market Volume (K) (2025-2032) By Type

Table 89: Europe Market Volume (K) (2025-2032) By Application

Table 90: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 91: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 92: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 93: South America Market Volume (K) (2025-2032) By Country

Table 94: South America Market Volume (K) (2025-2032) By Type

Table 95: South America Market Volume (K) (2025-2032) By Application

Table 96: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 97: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 98: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 99: Research Programs/Design For This Report

Table 100: Key Data Information From Secondary Sources

Table 101: Key Data Information From Primary Sources

FAQs

1. What is the current Medical Nitric Oxide market size?

The Medical Nitric Oxide market size surpassed USD 1.3 billion in 2023, driven by rising neonatal respiratory care and hospital adoption of precise NO delivery systems.

2. What growth rate is forecast for the Medical Nitric Oxide market through 2030?

Analysts project an 8% CAGR, pushing the Medical Nitric Oxide market toward USD 2.2 billion by 2030 on sustained pulmonary hypertension and chronic lung disease demand.

3. What are the primary growth drivers boosting Medical Nitric Oxide demand?

Key drivers include expanding neonatal intensive care units, favorable reimbursement for inhaled NO, and mounting evidence in adult COVID-19-related pulmonary fibrosis.

4. Which challenges currently restrain Medical Nitric Oxide market expansion?

High therapy cost, cylinder logistics, stringent NO handling protocols, and limited production sites outside North America restrain faster global uptake.

5. Which regions lead the global Medical Nitric Oxide market?

North America commands 52% share thanks to early approvals; Europe follows with Germany and France, while China and India show the fastest future outlook growth.

6. Who are the top companies shaping the Medical Nitric Oxide competitive landscape?

Mallinckrodt, Linde, Air Liquide, BOC Healthcare, and Beyond Air dominate supply contracts, delivery devices, and hold majority of FDA-approved NO drug labels.

7. What future opportunities could accelerate Medical Nitric Oxide market penetration?

Portable NO generators for home use, combination trials with stem-cell therapies, and emerging cardiac surgery applications present high-growth future opportunities.

8. How is technology impacting Medical Nitric Oxide delivery and monitoring?

Smart sensors, closed-loop titration algorithms, and real-time pulsed delivery reduce wastage, enhance dosing accuracy, and lower overall hospital NO procurement costs.

9. What does the regulatory landscape look like for Medical Nitric Oxide approvals?

FDA and EMA require validated analytical methods, NO2 limits below 0.05 ppm, and post-market pediatric safety data, guiding regional manufacturing compliance standards.

10. How is the Medical Nitric Oxide supply chain evolving?

Shift from sole-source sole-site to dual sourcing, strategic stock reserves, and regional fill-finish partnerships mitigate shortages and stabilize Medical Nitric Oxide market size growth.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Medical Nitric Oxide Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.25 billion
Revenue forecast in 2033	2.12 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Mallinckrodt; Praxair; Air Liquide
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options